Table 1.
Demographic, anamnestic, and clinical features of study participants.
| Patient characteristics | ||||
|---|---|---|---|---|
| Healthy controls | Migraine | Endometriosis | Migraine and endometriosis | |
| Age | 31.55 ± 1.71 | 32.74 ± 1.31 | 31.90 ± 1.02 | 35.70 ± 1.32 |
| BMI | 22.76 ± 3.09 | 24.11 ± 3.73 | 24.29 ± 4.13 | 23.76 ± 4.22 |
| Migraine characteristics | Endometriosis characteristics | ||||
|---|---|---|---|---|---|
| Migraine | Migraine and endometriosis | Endometriosis | Migraine and endometriosis | ||
| Years since migraine diagnosis | 16.16 ± 1.63 | 17.13 ± 2.06 | Years since endometriosis diagnosis | 3.03 ± 0.66 | 4.90 ± 1.09 |
| Monthly migraine days | 5.48 ± 0.57 | 4.53 ± 0.75 | Monthly days with endometriosis pain | 4.27 ± 0.77 | 5.48 ± 0.87 |
| Pain intensity | 7.19 ± 0.22 | 7.00 ± 0.29 | Pain intensity | 5.77 ± 0.46 | 6.43 ± 0.44 |
| Attack duration (h) | 28.92 ± 3.94 | 29.13 ± 4.94 | Attack duration (h) | 17.50 ± 3.27 | 26.77 ± 4.36 |
| Aura | 5 (17.9%) | 2 (8.0%) | rASRM score | 2.13 ± 0.22 | 2.08 ± 0.29 |
| Positive family history | 20 (71.4%) | 16 (64.0%) | Positive family history | 9 (33.3%) | 4 (16.0%) |
All values are reported as means (±standard error) or n (%).
Abbreviations: BMI, body mass index; NSAID, nonsteroidal anti‐inflammatory drugs; rASRM, revised classifications of the American Society for Reproductive Medicine.